GILD Stock UPDATES Gilead Sciences (GILD) 100.99 09/15/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 100.99 $GILD

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 50 mins ago
The EMDAC of the FDA recommended the approval of NPS Pharmaceuticals' Natpara.

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 55 mins ago
Alnylam (ALNY) expanded its pipeline with ALN-AGT a subcutaneously administrated RNAi therapeutic that targets AGT.

Gilead to license Sovaldi
at Investor's Business Daily - Mon Sep 15, 5:53PM CDT
The big-cap biotech is licensing its megasuccessful hepatitis C drug Sovaldi to Indian generic-drug makers such as Ranbaxy Labs and Cipla, in addition to U.S.-based Mylan (MYL). One course of the Gilead Sciences (GILD) treatment is currently $84,000...

Final Glance: Biotechnology companies
AP - Mon Sep 15, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Biogen/AbbVie Report Positive Data on MS Drug Zinbryta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:50PM CDT
Biogen Idec Inc. (BIIB) and partner AbbVie Inc. (ABBV) announced detailed positive results from the phase III study on Zinbryta.

Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:35PM CDT
Novartis (NVS) presented encouraging data on Lucentis and Jetrea at the EURETINA congress in London.

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 4:20PM CDT
Abbott Laboratories (ABT) announced positive one-year results from the randomized, controlled trial ABSORB II, on its drug-eluting coronary bioresorbable vascular scaffold (BVS) Absorb.

Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:45PM CDT
Amarin Corporation (AMRN) announced that the FDA's Office of New Drugs denied the company's appeal regarding the rescission of the Special Protocol Assessment covering the phase III ANCHOR study on Vascepa.

Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 2.58% Sell Off
Comtex SmarTrend(R) - Mon Sep 15, 3:39PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $99.33 to a high of $102.10. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $102.89 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of Gilead Sciences After 2.58% Loss
Comtex SmarTrend(R) - Mon Sep 15, 3:38PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $99.33 to a high of $102.10. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $102.89 on volume of 18.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Alere and Avanir are big market movers
AP - Mon Sep 15, 3:33PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 3:30PM CDT
Eli Lilly and Company (LLY) announced that Cyramza met the primary endpoint in a phase III study (RAISE) conducted in patients suffering from metastatic colorectal cancer.

Genomic Health Reveals Positive Oncotype DX Test Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 2:00PM CDT
Currently, Genomic Health (GHDX) is focused on boosting its Oncotype DX portfolio in the international market

Midday Glance: Biotechnology companies
AP - Mon Sep 15, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:

3 Reasons McKesson Corporation's Stock Could Rise
Keith Speights, The Motley Fool - Motley Fool - Mon Sep 15, 12:00PM CDT
Biotechs aren't the only hot healthcare stocks. Just look at pharmaceutical distributor and healthcare technology giant McKesson Corporation . It's up around 20% so far this year and has more than doubled over the last couple of years. Can these...

Jim Cramer Answers Twitter (TWTR) Questions on Alibaba IPO, Yahoo! (YHOO), Apple (AAPL) and More
at The Street - Mon Sep 15, 11:47AM CDT
TheStreet's Jim Cramer answers Twitter (TWTR) questions from the floor of the New York Stock Exchange, and he first tackles the upcoming Alibaba IPO.

Video: Gilead OKs Generic Sovaldi To Expand Access
at Investor's Business Daily - Mon Sep 15, 10:35AM CDT
Big-cap biotech and IBD 50 stock Gilead Sciences (GILD) said Monday that it's licensing its megablockbuster hepatitis C drug Sovaldi to seven Indian generic-drug companies to improve access in 91 developing countries. Gilead's stock fell about 2% on...

Why Is Gilead Sciences, Inc. Stock Offering This Drug for Cheap?
Todd Campbell, The Motley Fool - Motley Fool - Mon Sep 15, 10:25AM CDT
Gilead Sciences' Sovaldi has been a game changing therapy for thousands of patients in America and Europe, but patients living in poverty stricken countries in Africa and Asia have been shut out from the drug, which costs $84,000 for 12 weeks of...

Early Glance: Biotechnology companies
AP - Mon Sep 15, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:


Gilead to license generic version of Sovaldi
By TOM MURPHY - AP - Mon Sep 15, 9:05AM CDT
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

COP31 Tests Whether Climate Warnings Move Power Systems

Updated Category News Views 25

A weather alert that never reaches the control room is just expensive wallpaper. That was the useful, unsentimental thread running through a COP31 side event in Ankara on November 13: climate diplomacy is not worth much if grid operators, project owners and financiers do not change what they do when the forecast turns ugly. Implementation Means Changing Operations COP31...

Continue Reading
Africa’s Digital Ownership Debate Gets More Serious

Updated Category News Views 107

Ownership was the uncomfortable word hanging over Cape Town on day two of Africa Tech Festival 2026, and frankly it should make investors sit up. Africa’s digital economy has no shortage of big promises, shiny AI demos or overseas executives talking about opportunity. The harder question is who funds the pipes, owns the data, makes the rules and actually keeps the...

Continue Reading
AV Access iDock B12 Chases the Growing Two-PC Desk Boom

Updated Category News Views 136

Cable spaghetti has become an oddly durable tax on anyone running a work laptop beside a gaming tower, and AV Access is taking a proper swing at it with the iDock B12. This is not some mystical new category; it is a KVM switch and docking station mashed together for a desk that has to serve two masters. Still, the company has aimed at the parts that usually get sacrificed...

Continue Reading
OFRM Recall Leaves Investors Facing Hard Questions

Updated Category News Views 70

Nothing wrecks a young consumer brand’s glow faster than a recall involving toddlers, and Once Upon A Farm has just learned that lesson in the ugliest possible way. On November 2, 2026, shares of NYSE:OFRM fell 37% to close at $9.44. That left the stock roughly 47% below its $18 IPO price. Those are not the garden-variety bruises of a weak quarter. That is the market...

Continue Reading
Mindstream’s Jordan AI Campus Faces Its First Real Test

Updated Category News Views 45

Jordan’s AI ambitions just got attached to a very large gas meter. Mindstream Energy has unveiled a plan for an AI-ready data-center campus at Al-Risha in Mafraq Governorate, built around dedicated natural-gas generation rather than a conventional dependence on the utility grid. The headline number is 400 megawatts of eventual capacity. The number that matters first is...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 98

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Palmer Holland Takes Natural Colors Across North America

Updated Category News Views 49

Natural food color sounds like a tidy little ingredient story until somebody tries to keep a blue beverage blue on a retail shelf. That is where Palmer Holland's new exclusive North American commercial arrangement with BOTANIKind gets interesting. This is not a flashy public-market transaction, and neither company has handed investors a revenue figure, volume target, or...

Continue Reading
GFT's Banking Leader Tag Puts Execution Risks Into Focus

Updated Category News Views 173

A banking overhaul is where glossy slides go to die. That is why GFT Technologies being named a Leader in QKS Group's 2026 SPARK Matrix for Digital Banking Services deserves a little more attention than the usual analyst-firm trumpet blast. This is not a prize for making a pretty mobile app. The work described here runs through strategy, architecture, core-platform...

Continue Reading
Pennsylvania Rebate Rules Matter Before Year-End Filing

Updated Category News Views 121

A missed rebate form can sting harder than most people expect, especially when a household has already spent the year watching property taxes, rent, groceries, and every other stubborn bill chew through fixed income. Pennsylvania’s Property Tax/Rent Rebate Program is not glamorous, and it is certainly not an investing story. It is, however, the kind of direct household...

Continue Reading
Africa Tech Awards Put Infrastructure Back in Focus

Updated Category News Views 92

Twelve trophies in Cape Town tell a more useful story than most glossy technology forecasts ever manage to. The Africa Tech Festival Awards 2026, announced on November 19 during the event's 29th annual gathering, cut across connectivity, telecoms, AI, cybersecurity, data centres, cloud, fintech, startups and enterprise transformation. That breadth matters. Africa's...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Announced by Halper Sadeh LLC for Shareholders

Updated Category News Views 131

Halper Sadeh LLC Launches Investigative Inquiry Halper Sadeh LLC, a firm advocating for investor rights, has initiated an investigation into two companies: ODP Corporation (NASDAQ: ODP) and Metsera, Inc. (NASDAQ: MTSR). The focus of this inquiry is to examine potential breaches of fiduciary duties and violations of federal securities laws that impact shareholders. Details...

Continue Reading
Gran Tierra Energy Expands Offering with $150 Million Notes Sale

Updated Category News Views 205

Gran Tierra Energy’s Strategic Offering Announcement Gran Tierra Energy Inc. (NASDAQ: GTE) has made an important move in its corporate strategy by unveiling an additional offering of $150 million through its 9.500% Senior Secured Amortizing Notes due in 2029. This decision underscores the company’s dedication to improving its financial standing and further financing...

Continue Reading
Upstart Unveils T-Prime: A New Era for AI Lending

Updated Category News Views 124

Introducing Upstart's T-Prime Lending Program Upstart (NASDAQ: UPST), an innovative player in the artificial intelligence (AI) lending landscape, has recently taken a significant step forward with the launch of its T-Prime lending program. This exciting initiative enhances the Upstart Referral Network, enabling financial institutions such as banks and credit unions to...

Continue Reading
Oncotelic Showcases Innovations in Cancer Research at SITC

Updated Category News Views 180

Oncotelic's Recent Contributions to Cancer Research Oncotelic Therapeutics, Inc. has recently made significant strides in the field of oncology by presenting its research efforts at a notable conference. Leading the charge is Dr. Cynthia Lee, who serves as the Vice President of Research and Development. Her commitment to advancing cancer treatments has made a profound...

Continue Reading
Mammoth Energy Services Reports Q3 2024 Performance Highlights

Updated Category News Views 242

Mammoth Energy Services Reports Q3 2024 Performance Highlights Mammoth Energy Services, Inc. (NASDAQ: TUSK) recently shared its operational and financial results for the third quarter, revealing encouraging developments within its business sectors. Arty Straehla, the Chief Executive Officer, expressed optimism about the future, highlighting a hopeful turnaround in their...

Continue Reading